The Diagnostic Odyssey: Proving the Hormone Peak
At a Glance
Diagnosing Cushing disease is a multi-step process that starts with proving excess cortisol through urine, saliva, or blood tests. Because many pituitary tumors are too small to see on an MRI, an advanced procedure called IPSS is often needed to pinpoint the tumor's exact location.
The process of diagnosing Cushing disease is often compared to solving a high-stakes puzzle. Because the body’s cortisol levels naturally rise and fall throughout the day, a single blood test is almost never enough to confirm the diagnosis [1]. Instead, doctors follow a strict, multi-step process designed to prove that your body is producing too much cortisol and, crucially, to find exactly where it is coming from [2].
Step 1: Proving the Excess (Initial Screening)
Before looking for a tumor, your doctors must confirm you have hypercortisolism (too much cortisol). International guidelines generally require at least two abnormal results from the following three tests to move forward [2]:
- 24-Hour Urinary Free Cortisol (UFC): You collect your urine over a full 24-hour period. This measures the total amount of “free” (active) cortisol your body produced that day [2].
- Late-Night Salivary Cortisol (LNSC): Cortisol should be at its lowest point at midnight. By swabbing your mouth at night, doctors can see if your “internal clock” for cortisol has been broken. This test is highly sensitive, often exceeding 90% accuracy [1][3].
- Low-Dose Dexamethasone Suppression Test (DST): You take a small dose of a synthetic steroid (dexamethasone) at 11:00 PM and have your blood drawn the next morning. In a healthy person, the brain sees this “extra” steroid and tells the body to stop making its own cortisol. In Cushing disease, the body ignores the signal and continues to produce cortisol [2].
Step 2: The Imaging Problem
Once high cortisol is confirmed, the next step is an MRI of the pituitary gland. However, this is where many patients face a significant hurdle: The Invisible Tumor.
Most Cushing-related tumors are microadenomas, meaning they are smaller than 10 millimeters [4]. Many are so tiny (2–3 mm) that they do not show up on a standard MRI scan [5].
- Important Fact: A “negative” MRI does not mean you do not have Cushing disease. Up to 40% of patients with confirmed Cushing disease have an MRI that looks completely normal [6].
- The Technology Gap: If possible, doctors prefer using a 3-Tesla (3T) MRI, which provides much higher resolution than the older 1.5T machines, making these tiny tumors easier to spot [5].
Step 3: Finding the Source (The Gold Standard)
If your labs show high cortisol but your MRI is negative or inconclusive, your doctor will likely recommend Inferior Petrosal Sinus Sampling (IPSS) [7].
IPSS is considered the “gold standard” for identifying the source of the problem [8]. During this procedure, an interventional radiologist threads small catheters through the veins to the petrosal sinuses—the veins that drain blood directly from the pituitary gland.
- Why it’s done: The radiologist takes blood samples from both the pituitary area and a vein in your arm at the same time. If the ACTH level is significantly higher near the pituitary, it proves the tumor is located there rather than somewhere else in the body (like the lungs) [9].
- Stimulation: During the test, you will be given a medication (CRH or desmopressin) to “provoke” the tumor into releasing ACTH, which makes the results much clearer [10][11].
- Prolactin Normalization: To ensure the test is 100% accurate, doctors often measure prolactin (another pituitary hormone) at the same time. This confirms the catheters were placed exactly where they needed to be to catch the hormone “leak” [12][13].
This testing journey can be exhausting and repetitive, but each step is vital to ensure that when you move to treatment, your medical team is targeting the exact right spot.
Common questions in this guide
What tests are used to diagnose Cushing disease?
Why didn't my pituitary tumor show up on my MRI?
What is an IPSS procedure for Cushing disease?
Can medications interfere with my cortisol tests?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which two screening tests did I have, and how far above the normal range were my results?
- 2.Was my pituitary MRI performed on a 3T (3-Tesla) machine with a specialized 'pituitary protocol'?
- 3.If my MRI was negative, are we proceeding to IPSS, or do you recommend advanced imaging like 68Ga-DOTATATE PET?
- 4.During the IPSS, will you use desmopressin or CRH to stimulate the hormones, and will you measure prolactin to ensure the catheters were placed correctly?
- 5.How do you decide if my case is 'borderline' or if we need to repeat the screening over several weeks?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing's syndrome).
Raff H
Pituitary 2022; (25(5)):698-700 doi:10.1007/s11102-022-01214-2.
PMID: 35334030 - 2
Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives.
Carton T, Mathieu E, Wolff F, et al.
Endocrinology, diabetes & metabolism 2021; (4(3)):e00255 doi:10.1002/edm2.255.
PMID: 34277979 - 3
Late-Night Salivary Cortisol: Cut-Off Definition and Diagnostic Accuracy for Cushing's Syndrome in a Portuguese Population.
Lages AS, Frade JG, Oliveira D, et al.
Acta medica portuguesa 2019; (32(5)):381-387 doi:10.20344/amp.11265.
PMID: 31166899 - 4
Cushing Disease: Medical and Surgical Considerations.
Bray DP, Rindler RS, Dawoud RA, et al.
Otolaryngologic clinics of North America 2022; (55(2)):315-329 doi:10.1016/j.otc.2021.12.006.
PMID: 35256173 - 5
MRI for Cushing Disease: A Systematic Review.
Castle-Kirszbaum M, Amukotuwa S, Fuller P, et al.
AJNR. American journal of neuroradiology 2023; (44(3)):311-316 doi:10.3174/ajnr.A7789.
PMID: 36759141 - 6
[18F]FET PET/MRI: An Accurate Technique for Detection of Small Functional Pituitary Tumors.
Pruis IJ, Verburg FA, Balvers RK, et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2024; (65(5)):688-692 doi:10.2967/jnumed.123.266853.
PMID: 38514085 - 7
Inferior petrosal sinus sampling in Cushing's syndrome: usefulness and pitfalls.
Vassiliadi DA, Mourelatos P, Kratimenos T, Tsagarakis S
Endocrine 2021; (73(3)):530-539 doi:10.1007/s12020-021-02764-4.
PMID: 34080096 - 8
Bilateral inferior petrosal sinus sampling in the diagnosis of ACTH-dependent Cushing's syndrome: experience in a tertiary hospital.
Moreno Parro I, Ortiz Sánchez D, García Moreno R, et al.
Advances in laboratory medicine 2022; (3(3)):282-294 doi:10.1515/almed-2022-0088.
PMID: 37362143 - 9
Bilateral inferior petrosal sinus sampling: experience in 327 patients.
Deipolyi A, Bailin A, Hirsch JA, et al.
Journal of neurointerventional surgery 2017; (9(2)):196-199 doi:10.1136/neurintsurg-2015-012164.
PMID: 26880723 - 10
Lateralization outcomes of bilateral inferior petrosal sinus sampling: desmopressin vs CRH.
Erkan B, Cil MS, Cingoz M, et al.
Hormones (Athens, Greece) 2025; (24(2)):551-559 doi:10.1007/s42000-024-00620-4.
PMID: 39676152 - 11
A case series of bilateral inferior petrosal sinus sampling using desmopressin for evaluation of ACTH-dependent cushing's syndrome in pediatric patients: insights from Iran.
Valizadeh M, Rahmani F, Nikoohemmat M, et al.
Journal of diabetes and metabolic disorders 2025; (24(1)):125 doi:10.1007/s40200-025-01634-4.
PMID: 40416057 - 12
The diagnostic value of prolactin adjustment in bilateral inferior petrosal sinus sampling for differentiating Cushing's disease from the ectopic ACTH syndrome: a systematic review and meta-analysis.
Valizadeh M, Ahmadi AR, Hussein DR, et al.
Pituitary 2024; (28(1)):11 doi:10.1007/s11102-024-01474-0.
PMID: 39730909 - 13
[Diagnostic value of bilateral inferior petrosal sinus sampling in various modifications and methods of radiation and radionuclide imaging in the diagnosis and differential diagnosis of ACTH-dependent endogenous hypercortisolism].
Belaya ZE, Golounina OO, Sitkin II, et al.
Problemy endokrinologii 2024; (69(6)):4-16 doi:10.14341/probl13299.
PMID: 38311990
This page explains the diagnostic process and testing for Cushing disease for educational purposes only. Always consult your endocrinologist for medical advice and to interpret your specific test results.
Get notified when new evidence is published on Cushing disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.